APG system

Statement by the Prime Minister on the passing of Her Majesty Queen Elizabeth II

Retrieved on: 
Thursday, September 8, 2022
Time, Mourning, History, Affection, Commonwealth, Royal family, APG system, Government of Canada, 1939 royal tour of Canada

OTTAWA, ON, Sept. 8, 2022 /CNW/ - The Prime Minister, Justin Trudeau, today issued the following statement on the passing of Her Majesty Queen ElizabethII:

Key Points: 
  • OTTAWA, ON, Sept. 8, 2022 /CNW/ - The Prime Minister, Justin Trudeau, today issued the following statement on the passing of Her Majesty Queen ElizabethII:
    "It is with the heaviest of hearts that we learned of the passing of Canada's longest-reigning Sovereign, Her Majesty Queen ElizabethII.
  • Queen ElizabethII was a constant presence in our lives.
  • Over the course of 70 years and twenty-three Royal Tours, Queen ElizabethII sawthis country from coast to coast to coast and was there for our major, historical milestones.
  • "On behalf of the Government of Canada, I express our heartfelt condolences to members of the Royal Family during this most difficult time."

Message of the Governor General following the passing of Her Majesty Queen Elizabeth II

Retrieved on: 
Thursday, September 8, 2022
APG system, Memory, Royal family, The Queen, Love, Crown, Arctic

OTTAWA, ON, Sept. 8, 2022 /CNW/ - Today, my husband, Whit, and I join all Canadians in mourning the passing of our extraordinary sovereign, Her Majesty Queen Elizabeth II.

Key Points: 
  • OTTAWA, ON, Sept. 8, 2022 /CNW/ - Today, my husband, Whit, and I join all Canadians in mourning the passing of our extraordinary sovereign, Her Majesty Queen Elizabeth II.
  • Her Majesty The Queen was, in equal measures, compassionate, dedicated, humble, engaged and wise.
  • She believed in service to her people above all, and inspired so many with her dedication to the Crown.
  • When I was growing up, my grandmother revered The Queen, as did so many in the Arctic.

TRUE ROYALTY TV: Statement on the passing of Her Majesty Queen Elizabeth II

Retrieved on: 
Thursday, September 8, 2022
Death, Multimedia, Memory, Commonwealth, Work, Royal family, APG system, History, Elizabeth II, Time

On this sorrowful day, we are reminded of Her Majesty's own words in November last year, "None of us can slow the passage of time."

Key Points: 
  • On this sorrowful day, we are reminded of Her Majesty's own words in November last year, "None of us can slow the passage of time."
  • Queen Elizabeth II enjoyed a long and productive reign, touching the lives of millions around the world.
  • She dedicated her whole life to service and was the longest reigning monarch in Britishhistory.
  • We will be celebrating her 70 years on the throne and preserving the memory of her unparalleled reign.

Subang Parade Hosts Fashion Show at its Merdeka Fiesta

Retrieved on: 
Sunday, August 28, 2022
APG system, CEO, Clothing, As Syakirin Mosque, Friends, Batik, Culture, Subang Parade, Johari, Entertainment, Fashion, Retail, Hectare

Spectacular fashion showcase by Calvin Thoo and local designers at Batik, Tenun and Songket Fashion Show

Key Points: 
  • Spectacular fashion showcase by Calvin Thoo and local designers at Batik, Tenun and Songket Fashion Show
    KUALA LUMPUR, Aug 28, 2022 - (ACN Newswire) - Subang Parade, a core property owned by Hektar REIT, is pleased to announce the kick-off of Subang Parade Merdeka Fiesta weekend with an inaugural fashion show featuring local designers this afternoon.
  • Also in attendance were business associates, corporate figures and representatives from Subang Parade tenants.
  • Commenting on the weekend event, Johari said, "As the sponsor and a proud Malaysian, Subang Parade is honoured to present Merdeka Fiesta and today's Batik, Tenun and Songket Fashion Show.
  • The Subang Parade Merdeka Fiesta from 27 August to 31 August 2022 has activities lined up, including fashion shows, performances by local celebrities, a bazaar featuring locally made and produced merchandise, local cuisine cooking demonstrations, hobby demonstrations and a petting zoo to bring families, neighbours and friends together.

Color Star Technology and Emirates Travellers' Festival form a partnership, with international political and business leaders in attendance

Retrieved on: 
Tuesday, August 23, 2022
Metaverse, Software, Partnership, Security (finance), CEO, Technology, CSCW, View, United Arab Emirates, Artificial intelligence, Professional, Color, Achievement, R, Intelligence, Forward-looking statement, Review, Non-fungible token, U.S. Securities and Exchange Commission, Goal, Multimedia, APG system, Nasdaq, Company, Traveler, Private Securities Litigation Reform Act, Industry, Growth, Royal family, Life, Travel, Fireworks

Mr. Qadir said: "As the CEO of Color Star, I am very happy to be able to experience the charm of our metaverse software with everyone here.

Key Points: 
  • Mr. Qadir said: "As the CEO of Color Star, I am very happy to be able to experience the charm of our metaverse software with everyone here.
  • The partnership between Color Star and Emirates Travellers' Festival was the focus of the day's event.
  • And as such, Color Star will introduce to the world a new unique business model and profit point.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/color-star-technology-and-emira...
    SOURCE Color Star Technology Co., Ltd.

George D. Wendel, Jr., MD, to Retire as ABOG Executive Director in Late 2023

Retrieved on: 
Monday, August 1, 2022
Board, Medicine, GLOBE, MFM, Obstetrics, Evaluation, Female, Retirement, American Board of Commissioners for Foreign Missions, Assistant, Medical specialty, MD, ABOG, American Board of Medical Specialties, Gynecologic Oncology (journal), American Board of Obstetrics and Gynecology, APG system, Gynaecology, Certification, Infertility, Maintenance

Dallas, TX, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) announces the planned retirement of George D. Wendel, Jr., MD, Executive Director, effective December 31, 2023.

Key Points: 
  • Dallas, TX, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) announces the planned retirement of George D. Wendel, Jr., MD, Executive Director, effective December 31, 2023.
  • Dr. Wendel started his nearly 12-year-long career at ABOG as the Assistant to the Director of Evaluation in 2012.
  • Since 2017, Dr. Wendel has served as ABOGs Executive Director.
  • Dr. Wendel was an ABOG Specialty Certifying Examiner from 1995 through 2012 and a Maternal-Fetal Medicine (MFM) Examiner from 1996 through 2007.

Statement Regarding Misinformation and Disinformation and Medical Professionalism

Retrieved on: 
Thursday, July 7, 2022
Science, Patient, Legislation, Gynecologic Oncology (journal), GLOBE, COVID-19, American Board of Obstetrics and Gynecology, Obstetrics, Public health, Birth, Board, Medical specialty, Certification, American Board of Medical Specialties, ABOG, Evidence-based medicine, Health, Health policy, Maintenance, Female, APG system, Physician, American Board of Commissioners for Foreign Missions, Medicine, Birth control, Gynaecology, Infertility

Dallas, TX, July 07, 2022 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) issued a statement regarding Dissemination of COVID-19 Misinformation on September 27, 2021.

Key Points: 
  • Dallas, TX, July 07, 2022 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) issued a statement regarding Dissemination of COVID-19 Misinformation on September 27, 2021.
  • ABOG standards and policies for certification and maintenance of certification have clear expectations about medical professionalism and professional standing that physicians agree to as part of the certification process.
  • Misinformation and disinformation about contraception and abortion can create false narratives about essential safe practices in the specialty.
  • ABOG considers the dissemination of misinformation and disinformation that may threaten the health of the patients who place their trust in its diplomates to be a violation of medical professionalism.

ABOG Appoints New Board Officers and Members, Division Chair, and Members of Subspecialty Divisions

Retrieved on: 
Tuesday, July 5, 2022
University of Oklahoma College of Medicine, Gynecologic Oncology (journal), American Board of Obstetrics and Gynecology, Obstetrics, Board, Medical specialty, American Board of Medical Specialties, University, ABOG, Female, APG system, American Board of Commissioners for Foreign Missions, Medicine, Gynaecology, Infertility

Section Chief and Fellowship Director, Reproductive Endocrinology and Infertility

Key Points: 
  • Section Chief and Fellowship Director, Reproductive Endocrinology and Infertility
    Assistant Dean of Clinical Curriculum, University of Oklahoma College of Medicine
    The American Board of Obstetrics and Gynecology (ABOG) is an independent, non-profit organization that certifies obstetricians and gynecologists in the United States.
  • Founded in 1927, ABOG is one of 24 specialty Boards recognized by the American Board of Medical Specialties.
  • Based in Dallas, ABOG serves candidates and diplomates in the United States and Canada in the specialty of obstetrics and gynecology, plus several subspecialties, including Reproductive Endocrinology and Infertility; Maternal-Fetal Medicine; Gynecologic Oncology; Female Pelvic Medicine and Reconstructive Surgery; and Complex Family Planning.

Ari Zoldan joins Ritossa Global Family Office Investment Summit Under the High Patronage of His Serene Highness Prince Albert II of Monaco

Retrieved on: 
Monday, June 27, 2022
United Nations, Private, GLOBE, Marketing, Industry, BNP Paribas, Nobel Peace Prize, National Press Club (United States), Barclays Investment Bank, Yeshiva University, City college, Bankers Trust, Student, CNN, Entrepreneurship, US, Development, 2010 Nobel Peace Prize, Innovation, LLC, Investment, Advisory board, Press club, APG system, Fairmont, Morgan Stanley, First Nations in Ontario, CEO, Capitol Hill, CNBC, Deutsche Bank, Monte Carlo, Partnership, Fox News, Technology, News, Partner, The Fred Hollows Foundation, IBM, Media, Berkshire, Private officer of arms, IHeartRadio, Senior advisor, Family, Sandro Salsano, Management, Nomura

Monte-Carlo, Monaco, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Media Group, LLC today announced a media partnership with the Ritossa Global Family Office Investment Summit taking place June 27th-29th, 2022, at the Fairmont Monte-Carlo Hotel in Monaco.

Key Points: 
  • We are delighted to welcome Ari Zoldan to Monaco this year, said Sir Anthony Ritossa, chairman of the Ritossa Family Office.
  • Sir Anthony Ritossa is a family office influencer and thematic investor with interests in private equity, real estate, and blockchain companies.
  • The theme for the Monaco summit will be: "Family Offices Working Together to Invest for a Brighter Future.
  • Were excited to be entering this new era with Sir Anthony Ritossa, Quantum Media CEO Ari Zoldan said.

XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer Study

Retrieved on: 
Monday, June 20, 2022
Antibody, Time, Industry, The True Cost, Risk, Pancreatic cancer, Organic acid, Inflammation, Arm, Cancer, DLT, Oncology, Forward-looking statement, Growth, Disease, Irinotecan, Infection, APG system, NASDAQ, Phase, SEC, Incidence, Medicine, Patient, Terminology, Providence, Toxicity, Progression-free survival, GLOBE, Neoplasm, Pharmaceutical industry, Vaccine, Hematology

AUSTIN, Texas, June 20, 2022 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today it successfully completed the Phase I portion of its 1-BETTER study, a Phase I/II randomized, double-blind, placebo-controlled clinical study to evaluate its anti-cancer drug Natrunix in combination with chemotherapy for treating pancreatic cancer.

Key Points: 
  • AUSTIN, Texas, June 20, 2022 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today it successfully completed the Phase I portion of its 1-BETTER study, a Phase I/II randomized, double-blind, placebo-controlled clinical study to evaluate its anti-cancer drug Natrunix in combination with chemotherapy for treating pancreatic cancer.
  • Thirty leading cancer centers across the United States are involved in the Phase I/II study.
  • Pancreatic cancer is the 4th leading cause of cancer death in the United States and the incidence has been increasing steadily since 2000.
  • In 2022 about 50,000 people will die from pancreatic cancer in the United States.